Doctor profile · Federal record

Dr. Lori Spencer, MD PHD

Dermatology Physician (CMS: Dermatology) · Newark, DE

  • NPI 1871797936
  • Accepts Medicare
  • MIPS 75.6 / 100 · 2023
  • 22 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
537 Stanton Christiana RD, Suite #207
Newark, DE 19713
(302) 633-7550
fax (302) 225-3774

Credentials & registration

NPPES · NUCC
NPI registered
June 2007 — 19 yrs on file
Profile last updated
July 14, 2008
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Delaware #C10008690

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1871797936. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
23,615
Distinct HCPCS
10
Medicare allowed
$597,984
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 16,401 45 $2
99213 Established patient office or other outpatient visit, 20-29 minutes 1,867 1,367 $91
17003 Destruction of precancer skin growth, 2-14 growths 1,744 353 $7
17000 Destruction of precancer skin growth, 1 growth 740 559 $55
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application 634 46 $120
17110 Destruction of skin growth, 1-14 growths 527 432 $114
11102 Biopsy of related skin growth, first growth 433 364 $94
99214 Established patient office or other outpatient visit, 30-39 minutes 298 203 $128
99212 Established patient office or other outpatient visit, 10-19 minutes 203 175 $56
11103 Biopsy of related skin growth, each additional growth 186 98 $51

In context: peer comparison

Among 2 peers in Newark Dermatology Physician, average services per provider: 619. This provider delivers 38× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,990
Transactions
105
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 15 $249.36
Leo Pharma INC. 19 $236.63
Novartis Pharmaceuticals Corporation 10 $199.97
Dermavant Sciences, INC. 15 $195.09
Pfizer INC. 7 $181.66
Ucb, INC. 4 $179.51
Arcutis Biotherapeutics, INC. 11 $171.67
E.R. Squibb & Sons, L.L.C. 9 $150.52
Janssen Biotech, INC. 2 $96.22
Incyte Corporation 3 $81.71
Amgen INC. 3 $69.92
Ortho Dermatologics, A Division of Bausch Health US, LLC 2 $41.13
Genzyme Corporation 2 $34.79
Lilly USA, LLC 2 $33.08
Mallinckrodt Hospital Products INC. 1 $26.54

By nature of payment

Food and Beverage
$1,910
Education
$80

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,085
Patients
701
Total drug cost
$40,897
Drug Type Claims Patients Total cost
Ketoconazole Generic 208 122 $4,620
Triamcinolone Acetonide Generic 181 133 $1,804
Clobetasol Propionate Generic 124 71 $8,943
Fluorouracil Generic 101 89 $8,734
Hydrocortisone Generic 71 52 $598
Metronidazole Generic 66 41 $5,128
Minoxidil Generic 61 19 $388
Doxycycline Hyclate Generic 58 32 $2,687
Mupirocin Generic 52 40 $534
Imiquimod Generic 35 20 $1,268

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Lori Spencer's medical specialty?
Dr. Lori Spencer practices Dermatology Physician in Newark, DE.
Where does Dr. Lori Spencer practice?
Dr. Lori Spencer practices at 537 Stanton Christiana RD, Newark, DE 19713. Office phone: 3026337550.
What is Dr. Lori Spencer's NPI?
Dr. Lori Spencer's National Provider Identifier (NPI) is 1871797936, issued by NPPES.
Does Dr. Lori Spencer accept Medicare assignment?
Yes. Dr. Lori Spencer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lori Spencer commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.